AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The trial, which will enroll 140 subjects, is taking place at Duke University Medical Center, Durham, North Carolina, under the direction of Dr. Arthur Haney, Professor of Obstetrics and Gynecology and at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, under the direction of Dr. Stephen Corson, Professor of Obstetrics and Gynecology and Section Head of Reproductive Endocrinology. Patient interest at both trial centers has been high with results expected during fourth quarter of 2001.
2001 JUN 14 - (NewsRx Network) -- Pheromone Sciences Corp (PHS) has begun patient recruitment in a U.S.-based multicenter efficacy trial of its PSC Fertility Monitor [TM]
"We are very pleased that the interest to participate in this trial is so strong within our community," commented Haney. "As a non-invasive device that provides users with the opportunity to carry out home testing without urine or blood samples, the PSC Fertility Monitor offers a new ...